TITLE

J&J's Mylanta Sees $20M, PM SKU

AUTHOR(S)
Bittar, Christine
PUB. DATE
May 2000
SOURCE
Brandweek;05/29/2000, Vol. 41 Issue 22, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the advertising campaign for Johnson & Johnson/Merck & Company's Mylanta Night Time Strength liquid antacid. Advertising cost; Reasons for the decline in the sales of the antacid for months ending March 26, 2000; Target market for the antacid.
ACCESSION #
3207021

 

Related Articles

  • J&J Hopes Vanilla Licks Taste Issue. Bittar, Christine // Brandweek;10/04/99, Vol. 40 Issue 37, p4 

    Reports that Johnson and Johnson/Merck (J&J) is adding vanilla to its antacid brand, Mylanta Supreme. Suggestion of J&J to retailers on how to sell the brand; Complaint of the consumers against the brand; Decline of Mylanta's sales for fiscal year ended April 25, 1999.

  • Major push for Pepcid.  // Drug Topics;6/12/95, Vol. 139 Issue 11, p7 

    Reports on Johnson & Johnson/Merck's spending of about 100$ million to advertise and promote Pepcid.

  • J&J plots supreme command. Bittar, Christine // Brandweek;11/16/98, Vol. 39 Issue 43, p1 

    Reports on Johnson & Johnson/Merck's launch of an advertising and sampling campaign designed to reinvigorate its beleaguered Mylanta brand. Plan to launch the Fast Acting Mylanta Supreme across the first half of 1999; Major competitors of Mylanta in the over-the-counter segment; Publication of...

  • J&J/Merck's Pepcid races to OTC. Wilke, Michael // Advertising Age;5/29/1995, Vol. 66 Issue 22, p12 

    Reports on the launching of Johnson & Johnson/Merck's over-the-counter (OTC) antacid, Pepcid AC in the United States. Implications for the stomach remedies market; OTC approval from the Food & Drug Administration; Mechanism of action; Similar products waiting in line; Plans for marketing support...

  • Rhino Is Complete For Pepcid.  // SHOOT;04/20/2001, Vol. 42 Issue 16, p19 

    Presents information on the production of television commercials for Johnson & Johnson Co. and Merck Consumer Pharmaceuticals Co.'s antacid brand, by Saatchi & Saatchi New York. Production company; Editorial; Post/visual effects; Audio post; Music/sound design; Theme of the commercial.

  • Mylanta Pumps $35M For Chewy, Extra Calcium. Bittar, Christine // Brandweek;11/22/99, Vol. 40 Issue 44, p5 

    Announces the launching of an antacid lineup from Johnson and Johnson/Merck. Budget alloted for the product launch; Selling points of the company's rival product which it is trying to outdo; Description of the product features.

  • OTC Thought Letters. Breitstein, Joanna // Pharmaceutical Executive;Apr2003, Vol. 23 Issue 4, p71 

    Reports on Johnson & Johnson-Merck Consumer Pharmaceuticals' co-venture for the launching of a product message campaign in support for the heartburn drug Pepcid Complete. Emphasis on the consultative rapport between pharmacists and patients; Inclusion of a consumer education kit; Marketing...

  • New J&J brand targets digestion problems.  // Marketing Week;7/2/1998, Vol. 21 Issue 18, p8 

    Reports on the plans of consumer pharmaceutical company Johnson and Johnson (J&J) Merck Sharp Dohme (MSD), to create a drug category to treat digestion problems with the launch of Domperidone. Statement issued by J&J on the creation of the category; Comments by the company on Domperidone;...

  • Getting Pepcid In Better Shape. Bittar, Christine // Brandweek;10/04/99, Vol. 40 Issue 37, p1 

    Focuses on the marketing strategy of Johnson and Johnson/Merck (J&J) for its antacid brand, Pepcid Gelcaps. Argument of J&J advertising campaign for Gelcaps; Decline of Pepcid sales for the first four months of 1999; Investment plan for the product.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics